Esperion Therapeutics
ESPR
#7791
Rank
NZ$0.44 B
Marketcap
$2.24
Share price
-6.47%
Change (1 day)
-53.55%
Change (1 year)

P/S ratio for Esperion Therapeutics (ESPR)

P/S ratio as of April 2025 (TTM): 0.7889

According to Esperion Therapeutics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -0.6744. At the end of 2024 the company had a P/S ratio of 1.35.

P/S ratio history for Esperion Therapeutics from 2013 to 2024

PS ratio at the end of each year

Year P/S ratio Change
20241.35-53.75%
20232.92-51.95%
20226.0856.69%
20213.8831.08%
20202.96-73.21%
201911.1
2018N/A
2017N/A
2016N/A
2015N/A
2014N/A
2013N/A

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
5.88 645.13%๐Ÿ‡บ๐Ÿ‡ธ USA
4.54 475.29%๐Ÿ‡บ๐Ÿ‡ธ USA
2.19 177.58%๐Ÿ‡บ๐Ÿ‡ธ USA
4.73 499.41%๐Ÿ‡บ๐Ÿ‡ธ USA
4.60 483.51%๐Ÿ‡บ๐Ÿ‡ธ USA
5.59 608.13%๐Ÿ‡บ๐Ÿ‡ธ USA